ライフサイエンスコーパス: cyclic adenosine monophosphate

1 s of inosine, an adenosine surrogate, and of cyclic adenosine monophosphate.

2 edema toxin fails to increase intracellular cyclic adenosine monophosphate.

3 ays, as a phosphate donor or a precursor for cyclic adenosine monophosphate.

4 echanism acting through protein kinase A and cyclic adenosine monophosphate.

5 nhibits myelin gene activation by Krox-20 or cyclic adenosine monophosphate.

6 ng an exchange protein directly activated by cyclic adenosine monophosphate 1 (EPAC1)-RAP1-dependent

7 The nucleotide signaling molecule 3',5'-cyclic adenosine monophosphate (3',5'-cAMP) plays import

8 utocrine stimulation of A2a receptors causes cyclic adenosine monophosphate accumulation at the back

9 The cystic fibrosis gene encodes a cyclic adenosine monophosphate-activated chloride channe

10 the supernatant and increased intracellular cyclic adenosine monophosphate activity.

11 ivating transcription factor 2 (ATF2) to the cyclic adenosine monophosphate (AMP) response element (C

12 tor and is mediated via up-regulation of the cyclic adenosine monophosphate (AMP)/protein kinase A pa

13 Glucagon and a cyclic adenosine monophosphate analog increased promoter

14 activate its transcription in response to a cyclic adenosine monophosphate analog.

15 ained in culture and treated with either the cyclic adenosine monophosphate analogue 8-(4-chloropheny

16 sing Xenopus oocytes in the presence of both cyclic adenosine monophosphate and Ca(2+) results in Ca(

17 A is an enzyme involved in the regulation of cyclic adenosine monophosphate and cyclic guanosine mono

18 es that regulate the intracellular levels of cyclic adenosine monophosphate and cyclic guanosine mono

19 ndent signaling pathway that is dependent on cyclic adenosine monophosphate and extracellular signal-

20 ded in culture and decidualized with 8-bromo-cyclic adenosine monophosphate and medroxyprogesterone a

21 ffeine increases CcOX activity by increasing cyclic adenosine monophosphate and protein kinase A acti

22 flagella, the second messengers calcium and cyclic adenosine monophosphate are implicated in modulat

23 In 3,5-cyclic adenosine monophosphate assays, the novel series

24 Strikingly, the measured on-rate for cyclic adenosine monophosphate binding is two orders of

25 Cyclic adenosine monophosphate binding not only unleashe

26 tions in ADCY5 was studied by measurement of cyclic adenosine monophosphate (cAMP) accumulation under

27 d by either a selective alpha2 antagonist, a cyclic adenosine monophosphate (cAMP) analogue, or an ad

28 s animal had an impaired capacity to degrade cyclic adenosine monophosphate (cAMP) and a blunted phar

29 Ucn1 is mediated initially by an increase in cyclic adenosine monophosphate (cAMP) and a subsequent i

30 Diminished cyclic adenosine monophosphate (cAMP) and augmented cycl

31 Interactions between cyclic adenosine monophosphate (cAMP) and Ca(2+) are wid

32 The cyclic adenosine monophosphate (cAMP) and Ca(2+) signali

33 Cytosolic cyclic adenosine monophosphate (cAMP) and cyclic guanosi

34 PDE11A4, which degrades cyclic adenosine monophosphate (cAMP) and cyclic guanosi

35 These second messengers include cyclic adenosine monophosphate (cAMP) and cyclic guanosi

36 Cyclic adenosine monophosphate (cAMP) and cyclic guanosi

37 he regulation of the intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosi

38 The spatiotemporal regulation of cyclic adenosine monophosphate (cAMP) and its dynamic in

39 lationship between NMDA-induced increases in cyclic adenosine monophosphate (cAMP) and learning and m

40 Cyclic adenosine monophosphate (cAMP) and protein kinase

41 r1a (Prkar1a(+/-)), the primary receptor for cyclic adenosine monophosphate (cAMP) and regulator of p

42 This contributed to an increase in basal cyclic adenosine monophosphate (cAMP) and vasodilator-st

43 In 3,5-cyclic adenosine monophosphate (cAMP) assays, the novel

44 In 3,5-cyclic adenosine monophosphate (cAMP) assays, the novel

45 behaved as a PTH1R antagonist in cell-based cyclic adenosine monophosphate (cAMP) assays, with selec

46 ion and prostaglandin E1-induced increase in cyclic adenosine monophosphate (cAMP) by ADP was impaire

47 Elevation of cyclic adenosine monophosphate (cAMP) can mimic axonal c

48 asic studies exploring the importance of the cyclic adenosine monophosphate (cAMP) cascade in major d

49 ype IV (PDE4), an important component of the cyclic adenosine monophosphate (cAMP) cascade, selective

50 A) R-subunit through formation of a PDE-PKAR-cyclic adenosine monophosphate (cAMP) complex (the termi

51 hanistically, coronin 1-deficiency increased cyclic adenosine monophosphate (cAMP) concentrations to

52 Neuropeptides that exert cyclic adenosine monophosphate (cAMP) dependent effects

53 Cyclic adenosine monophosphate (cAMP) drives genetic pol

54 In Schwann cells (SCs), cyclic adenosine monophosphate (cAMP) enhances the actio

55 Elevation of cyclic adenosine monophosphate (cAMP) following cell det

56 rtery smooth muscle cells (hCASMCs) to 3',5'-cyclic adenosine monophosphate (cAMP) generation and pho

57 Cyclic adenosine monophosphate (cAMP) has been intensive

58 4 phosphodiesterase (PDE4) and elevation of cyclic adenosine monophosphate (cAMP) has emerged as a p

59 Tadalafil selectively increased cGMP but not cyclic adenosine monophosphate (cAMP) in brain.

60 sease is associated with increased levels of cyclic adenosine monophosphate (cAMP) in cholangiocytes

61 ing technology have revealed oscillations of cyclic adenosine monophosphate (cAMP) in insulin-secreti

62 the concentration of the secondary messenger cyclic adenosine monophosphate (cAMP) in MLT cells, in r

63 reported to do so by only D1 receptor-driven cyclic adenosine monophosphate (cAMP) increases or D2 re

64 ieval from the canalicular membrane, whereas cyclic adenosine monophosphate (cAMP) increases plasma m

65 Cyclic adenosine monophosphate (cAMP) is a nearly ubiqui

66 3',5'-Cyclic adenosine monophosphate (cAMP) is a pivotal secon

67 Cyclic adenosine monophosphate (cAMP) is a second messen

68 Cyclic adenosine monophosphate (cAMP) is an important me

69 Cyclic adenosine monophosphate (cAMP) is generated by ad

70 Cyclic adenosine monophosphate (cAMP) is very important

71 encodes a PDE that regulates cardiac myocyte cyclic adenosine monophosphate (cAMP) levels and myocard

72 While increased cyclic adenosine monophosphate (cAMP) levels are known t

73 E3A inhibitor, cilostazol, to modulate 3',5'-cyclic adenosine monophosphate (cAMP) levels in an in vi

74 in intrahepatic bile duct units (IBDUs) and cyclic adenosine monophosphate (cAMP) levels in cholangi

75 lpha inhibitory protein Galpha(o1) to reduce cyclic adenosine monophosphate (cAMP) levels in mice and

76 r (PLD) and kidney (PKD) diseases, increased cyclic adenosine monophosphate (cAMP) levels trigger hep

77 Intracellular cyclic adenosine monophosphate (cAMP) levels tune the vo

78 In contrast, basal cyclic adenosine monophosphate (cAMP) levels, agonist-st

79 l methods such as elevation of intracellular cyclic adenosine monophosphate (cAMP) levels, and depend

80 E17G increased cyclic adenosine monophosphate (cAMP) levels, and this i

81 tivation in HT-29-EP4 cells was elevation of cyclic adenosine monophosphate (cAMP) levels, which was

82 agonists that raise intracellular Ca(2+) or cyclic adenosine monophosphate (cAMP) levels.

83 r forskolin, both of which increase platelet cyclic adenosine monophosphate (cAMP) levels.

84 ive binding, Matrigel invasion and Galpha(i) cyclic adenosine monophosphate (cAMP) modulation signali

85 re, our genetic analyses have identified the cyclic adenosine monophosphate (cAMP) pathway and a prev

86 ns in the GNAS gene, which encodes the 3',5'-cyclic adenosine monophosphate (cAMP) pathway-associated

87 This study was designed to examine whether a cyclic adenosine monophosphate (cAMP) phosphodiesterase

88 Type 4 cyclic adenosine monophosphate (cAMP) phosphodiesterase

89 The second messenger cyclic adenosine monophosphate (cAMP) plays a pivotal ro

90 mary cultures of LMMP neurons (PC-LMMPn) and cyclic adenosine monophosphate (cAMP) production in huma

91 ticoids alone can swiftly increase the 3',5'-cyclic adenosine monophosphate (cAMP) production.

92 e aggregation and morphogenesis by secreting cyclic adenosine monophosphate (cAMP) pulses that propag

93 receptors (GPCRs) other than the four known cyclic adenosine monophosphate (cAMP) receptors (cAR1-4)

94 illations and elevation of 3'-5' [corrected] cyclic adenosine monophosphate (cAMP) reduced cellular p

95 Cyclic adenosine monophosphate (cAMP) regulates long-ter

96 eared to have taken effect through increased cyclic adenosine monophosphate (cAMP) response element b

97 The transcription factor cyclic adenosine monophosphate (cAMP) response element b

98 fferential cocaine-induced activation of the cyclic adenosine monophosphate (cAMP) response element b

99 OPN3 negatively regulates the cyclic adenosine monophosphate (cAMP) response evoked by

100 Second, we found that phosphorylation of cyclic adenosine monophosphate (cAMP) responsive-element

101 Kinase A (PKA) is the major receptor for the cyclic adenosine monophosphate (cAMP) secondary messenge

102 mitogen-activated protein kinase (MAPK) and cyclic adenosine monophosphate (cAMP) signal transductio

103 DE4B), FTO augmented second messenger 3', 5'-cyclic adenosine monophosphate (cAMP) signaling and supp

104 can generate spatial compartmentalization of cyclic adenosine monophosphate (cAMP) signaling at the c

105 per, we demonstrate a differential effect of cyclic adenosine monophosphate (cAMP) signaling between

106 DISC1 also regulates cyclic adenosine monophosphate (cAMP) signaling by incre

107 Using a marker of the cyclic adenosine monophosphate (cAMP) signaling cascade

108 We report here that cocaine and cyclic adenosine monophosphate (cAMP) signaling induce t

109 ickle cell disease and activated through the cyclic adenosine monophosphate (cAMP) signaling pathway.

110 Termination of cyclic adenosine monophosphate (cAMP) signaling via the

111 terase 3 (PDE3) is an important regulator of cyclic adenosine monophosphate (cAMP) signaling within t

112 to bile duct ligation (BDL) by activation of cyclic adenosine monophosphate (cAMP) signaling.

113 gene encodes a membrane protein involved in cyclic adenosine monophosphate (cAMP) signaling.

114 hosphodiesterase 4D (PDE4D), which regulates cyclic adenosine monophosphate (cAMP) signaling.

115 Cyclic adenosine monophosphate (cAMP) stimulates hepatic

116 Cyclic adenosine monophosphate (cAMP) stimulates translo

117 Here we show that glucagon and cyclic adenosine monophosphate (cAMP) strongly repressed

118 treatment increased intracellular levels of cyclic adenosine monophosphate (cAMP) that turned on pro

119 e-dependent increases in secondary-messenger cyclic adenosine monophosphate (cAMP) to activate protei

120 Binding of 3',5'-cyclic adenosine monophosphate (cAMP) to hyperpolarizati

121 receptor D1 (DRD1) via the second messenger cyclic adenosine monophosphate (cAMP) to synthetic promo

122 devices were treated with Angiopoietin 1 and cyclic adenosine monophosphate (cAMP) to vary the Pd of

123 In this study, we showed that cyclic adenosine monophosphate (cAMP) treatment induced

124 nsive controlled release of both insulin and cyclic adenosine monophosphate (cAMP) was synthesized.

125 Levels of cyclic adenosine monophosphate (cAMP) were elevated over

126 evels of phenylalanine, acetylhistidine, and cyclic adenosine monophosphate (cAMP) were found in urin

127 s) regulate the local concentration of 3',5' cyclic adenosine monophosphate (cAMP) within cells.

128 cell-permeable non-hydrolysable analogue of cyclic adenosine monophosphate (cAMP), 8-Br-cAMP.

129 Here we demonstrate that cyclic adenosine monophosphate (cAMP), a second messenge

130 Here we examine whether increases in cyclic adenosine monophosphate (cAMP), an intracellular

131 s of both a small molecule second messenger, cyclic adenosine monophosphate (cAMP), and a downstream

132 tionally modulated by a HCN channel blocker, cyclic adenosine monophosphate (cAMP), and neuromodulato

133 ially orchestrated by waves of extracellular cyclic adenosine monophosphate (cAMP), and previous theo

134 In beta cells, Ca(2+), cyclic adenosine monophosphate (cAMP), and Protein Kinas

135 studies have implicated defective dopamine, cyclic adenosine monophosphate (cAMP), and Ras homeostas

136 gonist MRE-269 increased intracellular 3',5'-cyclic adenosine monophosphate (cAMP), augmented glucose

137 The second messenger, 3',5'-cyclic adenosine monophosphate (cAMP), is known to be mo

138 The cyclic adenosine monophosphate (cAMP), mitogen-activated

139 Dibutyryl cyclic adenosine monophosphate (cAMP), salmeterol, albut

140 with increased intracellular adenosine 3',5'-cyclic adenosine monophosphate (cAMP), the inhibition of

141 Cyclic adenosine monophosphate (cAMP), when added, induc

142 holoenzyme is one of the major receptors for cyclic adenosine monophosphate (cAMP), where an extracel

143 ith SCTR reduced ability of SCT to stimulate cyclic adenosine monophosphate (cAMP), with signaling au

144 en activated protein kinase (MAPK) and 3'-5'-cyclic adenosine monophosphate (cAMP)-associated signali

145 esynaptic function through activation of the cyclic adenosine monophosphate (cAMP)-cAMP-dependent pro

146 embrane conductance regulator (CFTR) gene, a cyclic Adenosine MonoPhosphate (cAMP)-dependent chloride

147 Here we studied the cyclic adenosine monophosphate (cAMP)-dependent gating i

148 Previously, we described a cyclic adenosine monophosphate (cAMP)-dependent increase

149 ht epithelial barrier can be up-regulated by cyclic adenosine monophosphate (cAMP)-dependent mechanis

150 almodulin-dependent kinase II (CaMKII) and a cyclic adenosine monophosphate (cAMP)-dependent pathway.

151 s of the regulatory subunit (PRKAR1A) of the cyclic adenosine monophosphate (cAMP)-dependent protein

152 Met) encoding the gamma-catalytic subunit of cyclic adenosine monophosphate (cAMP)-dependent protein

153 In its physiological state, cyclic adenosine monophosphate (cAMP)-dependent protein

154 2(+)(i))-dependent protein kinase C (PKC) or cyclic adenosine monophosphate (cAMP)-dependent protein

155 The catalytic (C) subunit of cyclic adenosine monophosphate (cAMP)-dependent protein

156 involved in the natural association between cyclic adenosine monophosphate (cAMP)-dependent protein

157 The 2.0-angstrom structure of the cyclic adenosine monophosphate (cAMP)-dependent protein

158 ow found that up-regulation of intracellular cyclic adenosine monophosphate (cAMP)-dependent protein

159 lates repulsive axon guidance by linking the cyclic adenosine monophosphate (cAMP)-dependent protein

160 Furthermore, we demonstrated that Tregs use cyclic adenosine monophosphate (cAMP)-dependent protein

161 tight spatiotemporal signaling control, the cyclic adenosine monophosphate (cAMP)-dependent protein

162 sed approach was applied to the prototypical cyclic adenosine monophosphate (cAMP)-dependent protein

163 Cyclic adenosine monophosphate (cAMP)-dependent signalin

164 Cyclic adenosine monophosphate (cAMP)-dependent signalin

165 dian rhythms of LC opsin mRNA expression via cyclic adenosine monophosphate (cAMP)-dependent signalin

166 -1, promotes beta cell Tcf7 expression via a cyclic adenosine monophosphate (cAMP)-independent and ex

167 a toxin (CT)-induced diarrhea is mediated by cyclic adenosine monophosphate (cAMP)-mediated active Cl

168 n of the aryl hydrocarbon receptor (AhR) and cyclic adenosine monophosphate (cAMP)-mediated signaling

169 regulation of NMJ growth occurs through the cyclic adenosine monophosphate (cAMP)-protein kinase A (

170 e somatodendritic domain, depends on ongoing cyclic adenosine monophosphate (cAMP)-protein kinase A (

171 d stimulation of the prostaglandin E2 (PGE2)-cyclic adenosine monophosphate (cAMP)-protein kinase A (

172 -kappaB), activator of protein-1 (AP-1), and cyclic adenosine monophosphate (cAMP)-responsive element

173 nd that genetic deletion of HCN2 removed the cyclic adenosine monophosphate (cAMP)-sensitive componen

174 sults from Cl(-)/HCO(3)(-) exchange, whereas cyclic adenosine monophosphate (cAMP)-stimulated secreti

175 entration gradient of the signaling molecule cyclic adenosine monophosphate (cAMP).

176 reported including increased levels of 3'-5'-cyclic adenosine monophosphate (cAMP).

177 causes a dramatic increase of intracellular cyclic adenosine monophosphate (cAMP).

178 se binding region (BBR) of EPAC1, similar to cyclic adenosine monophosphate (cAMP).

179 e and to lead to the autonomous synthesis of cyclic adenosine monophosphate (cAMP).

180 egulating production of the second messenger cyclic adenosine monophosphate (cAMP).

181 of the intracellular second messenger 3',5'-cyclic adenosine monophosphate (cAMP).

182 d adenylyl cyclase to increase intracellular cyclic adenosine monophosphate (cAMP).

183 le-cell chemotaxis towards emitted pulses of cyclic adenosine monophosphate (cAMP).

184 espite converging on a ubiquitous messenger, cyclic adenosine monophosphate (cAMP).

185 r(s) and an intrinsic platelet mechanism via cyclic adenosine monophosphate (cAMP)/adenylate cyclase,

186 of large cholangiocytes is regulated by the cyclic adenosine monophosphate (cAMP)/extracellular sign

187 poly(ADP-ribose) polymerase 1 (PARP1) by the cyclic adenosine monophosphate (cAMP)/protein kinase A (

188 In polycystin-2 (PC2)-defective mice, cyclic adenosine monophosphate (cAMP)/protein kinase A (

189 Downstream of calcium, the cyclic adenosine monophosphate (cAMP)/protein kinase A (

190 l cells by beta-adrenergic signaling through cyclic adenosine monophosphate (cAMP); however, the mech

191 ere identified as full antagonist ligands on cyclic adenosine monophosphate (cAMP, KB = 4.9 and 5.9 n

192 ed signaling pathway function (Ras activity, cyclic adenosine monophosphate [cAMP], and dopamine leve

193 e.g., glutamatergic, monoaminergic, calcium, cyclic adenosine monophosphate [cAMP], dopamine- and cAM

194 s phosphorylation of DARPP-32 (dopamine- and cyclic adenosine monophosphate [cAMP]-regulated phospho-

195 Coactivators p300 and CREB (cyclic adenosine monophosphate [cAMP]-response element b

196 ns and is regulated by opposing stimulatory (cyclic adenosine monophosphate, cAMP) and inhibitory (in

197 in zebrafish that post-injury application of cyclic adenosine monophosphate can transform severed CNS

198 odiesterase 10A (PDE10A), a dual-specificity cyclic adenosine monophosphate/cyclic guanosine monophos

199 h repeat kinase 2 was inhibited by dibutyryl-cyclic adenosine monophosphate, cytoplasmic expression o

200 homologous to the dimerization interface of cyclic adenosine monophosphate dependent PKA RII-alpha,

201 conditions that trigger the damage of large cyclic adenosine monophosphate-dependent cholangiocytes.

202 ; cyclic adenosine monophosphate levels; and cyclic adenosine monophosphate-dependent protein kinase

203 encoding the gamma-catalytic subunit of the cyclic adenosine monophosphate-dependent protein kinase,

204 etagamma, G protein-coupled receptor kinase, cyclic adenosine monophosphate-dependent protein kinase,

205 a mitogen-activated protein kinase cascade, cyclic adenosine monophosphate-dependent protein kinase,

206 PDGF-BB induced cyclic adenosine monophosphate-dependent protein kinase-

207 the activation of neuronal EP2 receptors and cyclic adenosine monophosphate-dependent protein kinase.

208 y phosphorylation of its headpiece domain by cyclic adenosine monophosphate-dependent protein kinase.

209 It is highly debated how cyclic adenosine monophosphate-dependent regulation (CDR

210 Optogenetic upregulation of cyclic adenosine monophosphate during the day increases

211 AVP/cyclic adenosine monophosphate enhance the phosphorylati

212 antagonists further confirmed by functional cyclic adenosine monophosphate experiments.

213 of adenylyl cyclase (AC) and an increase in cyclic adenosine monophosphate formation.

214 the ion channel hyperpolarization-activated cyclic adenosine monophosphate gated channel type 1 (HCN

215 AC(VI), unlike other strategies to increase cyclic adenosine monophosphate generation, reduces morta

216 essin (Normal: p < 0.001; HF: p < 0.01), and cyclic adenosine monophosphate (HF: p < 0.001).

217 on restores the suppressive effects of 3',5'-cyclic adenosine monophosphate in lymphocytes.

218 inase-3beta) is highly associated with cAMP (cyclic adenosine monophosphate)-independent dopamine D(2

219 al potency in inhibiting the accumulation of cyclic adenosine monophosphate induced by 5'- N-ethylcar

220 Cyclic adenosine monophosphate-induced enteroid intracel

221 C(IR800)-TOC demonstrated higher potency for cyclic adenosine monophosphate inhibition (half maximal

222 lus epithelium is required for intracellular cyclic adenosine monophosphate inhibition of Na(+)/H(+)

223 estion using a knockin mouse line expressing cyclic adenosine monophosphate-insensitive HCN4 channels

224 rotein (GP)IIb/IIIa activation and decreased cyclic adenosine monophosphate levels (n = 6, P < .01) i

225 occur in concert with an attenuated rise in cyclic adenosine monophosphate levels in response to pro

226 EP2 TG mice showed significantly increased cyclic adenosine monophosphate levels in the epidermis a

227 elease of neurotrophins together with raised cyclic adenosine monophosphate levels in treated culture

228 ung airway reactivity by modulating the lung cyclic adenosine monophosphate levels through changes in

229 VILIP-1 enhances cyclic adenosine monophosphate levels through PKA induct

230 g but was causally related to decreased lung cyclic adenosine monophosphate levels, increased phospho

231 t significantly alter airway responsiveness, cyclic adenosine monophosphate levels, or the phosphodie

232 ystolic function without changing myocardial cyclic adenosine monophosphate levels.

233 pression of the cardiac stress marker NR4A1; cyclic adenosine monophosphate levels; and cyclic adenos

234 ronin 1 that regulates the phosphodiesterase/cyclic adenosine monophosphate pathway and modulates T c

235 ted the ability of RvD5n-3 DPA to upregulate cyclic adenosine monophosphate, phagocytosis of bacteria

236 herapy with NgR(310)ecto-Fc plus rolipram, a cyclic adenosine monophosphate phosphodiesterase inhibit

237 (mitogen-activated protein kinase) and cAMP (cyclic adenosine monophosphate)-PKA (protein kinase A) c

238 ated that rolipram, an anti-inflammatory and cyclic adenosine monophosphate preserving small molecule

239 nal antagonist that inhibited CRF-stimulated cyclic adenosine monophosphate production and CRF-induce

240 sponse (UPR), intracellular ion homeostasis, cyclic adenosine monophosphate production and regulation

241 on, adenosine uptake by red blood cells, and cyclic adenosine monophosphate production by cells overe

242 and osteoclast differentiation by enhancing cyclic adenosine monophosphate production through an uni

243 on, while augmenting beta-agonist-stimulated cyclic adenosine monophosphate production.

244 estins also augments beta-agonist-stimulated cyclic adenosine monophosphate production.

245 4R, rather than canonical Galpha(s)-mediated cyclic adenosine-monophosphate production, explained 88%

246 cholangiocytes show increased production of cyclic adenosine monophosphate, protein kinase A-depende

247 that loss of actin stress fibers is due to a cyclic adenosine monophosphate, protein kinase A-mediate

248 echanism of ICAM-4 activation occurs via the cyclic adenosine monophosphate-protein kinase A (cAMP-PK

249 de monotherapy, which elevates intracellular cyclic adenosine monophosphate/protein kinase A (cAMP-PK

250 d prostacyclin which stimulates the platelet cyclic adenosine monophosphate/protein kinase A (cAMP/PK

251 Previous studies have implicated the cyclic adenosine monophosphate/protein kinase A pathway

252 g Western blot analysis, Oil-Red-O staining, cyclic adenosine monophosphate radioimmunoassay, immunof

253 estigated the role of DARPP-32 (dopamine and cyclic adenosine monophosphate-regulated phosphoprotein,

254 als that PGE(2) signal to HPK1 via a 3' -5 '-cyclic adenosine monophosphate-regulated, PKA-dependent

255 Cyclic adenosine monophosphate relaxes airway smooth mus

256 clear fractions by means of Western blot and cyclic adenosine monophosphate response element (CRE)-DN

257 d neurotrophic factor and phosphorylation of cyclic adenosine monophosphate response element binding

258 increases the levels of transcription factor cyclic adenosine monophosphate response element binding

259 running on the phosphorylation of Akt, AMPK, cyclic adenosine monophosphate response element binding

260 Cyclic adenosine monophosphate response element binding

261 -like factor 1 (ELF-1; between -49 and -52), cyclic adenosine monophosphate response element binding

262 A polymorphism near the cyclic adenosine monophosphate response element binding

263 Because cyclic adenosine monophosphate response element binding

264 These neurons also showed persistent cyclic adenosine monophosphate response element binding

265 ated protein kinase p42/p44 (MAPK(p42/p44)), cyclic adenosine monophosphate response element binding

266 Cyclic adenosine monophosphate response element binding

267 nvestigated the functional regulation of the cyclic adenosine monophosphate response element binding

268 nscriptional activity and phosphorylation of cyclic adenosine monophosphate response element binding

269 whereas expression of the binding protein of cyclic adenosine monophosphate response element binding

270 have shown that nuclear transcription factor cyclic adenosine monophosphate response element binding

271 wn of DISC1 caused a significant increase of cyclic adenosine monophosphate response element-binding

272 glycosylation of the transducer of regulated cyclic adenosine monophosphate response element-binding

273 activation and is required for signaling to cyclic adenosine monophosphate response element-binding

274 in homologous protein, and activation of the cyclic adenosine monophosphate response element-binding

275 promoter regions of the transcription factor cyclic adenosine monophosphate response element-binding

276 in vitro evaluation of H(3)R agonism using a cyclic adenosine monophosphate response element-lucifera

277 roximal promoter region as well as increased cyclic adenosine monophosphate response element-mediated

278 hancer binding protein-beta (C/EBPbeta), and cyclic adenosine monophosphate-response element binding

279 Here we identify cyclic adenosine monophosphate responsive element bindin

280 /ERK), leading to down-regulation of phospho-cyclic adenosine monophosphate responsive element-bindin

281 The transcription factor, cyclic adenosine monophosphate-responsive element modula

282 ation-transcription coupling caused by CREB (cyclic adenosine monophosphate-responsive element-bindin

283 Stimulation of intracellular cyclic adenosine monophosphate resulted in cessation of

284 The current study examined whether D1R-cyclic adenosine monophosphate signaling reduces neurona

285 of dopamine D1 receptor (D1R) activation of cyclic adenosine monophosphate signaling, which reduces

286 he effects of dopamine receptor D2 (DRD2) on cyclic adenosine monophosphate signaling; PDAC tissues h

287 REB, CRE-DNA binding activity, and basal and cyclic adenosine monophosphate-stimulated protein kinase

288 ion, we determined the catalytic activity of cyclic adenosine monophosphate-stimulated protein kinase

289 cell volume were unaffected by intracellular cyclic adenosine monophosphate stimulation in NKCC1(-) j

290 couple to ion channel Kir7.1, while lacking cyclic adenosine monophosphate stimulation, highlights a

291 es in CFTR(-) epithelium after intracellular cyclic adenosine monophosphate stimulation.

292 -mediated generation of the second messenger cyclic adenosine monophosphate, suggesting that alterati

293 Rap-1 is also activated directly by cyclic adenosine monophosphate through Epac, and thus pa

294 phodiesterase type 4 inhibitor and dibutyryl cyclic adenosine monophosphate to overcome myelin-mediat

295 A well-studied system is the binding of cyclic adenosine monophosphate to the cyclic nucleotide

296 transient loss of worm motility dependent on cyclic adenosine monophosphate, whereas transient photoa

297 ctor 3/exchange factor directly activated by cyclic adenosine monophosphate, which maintains vascular

298 Increases in cyclic adenosine monophosphate with forskolin caused ent

299 not respond to stimulation of intracellular cyclic adenosine monophosphate with inhibition of electr

300 O, guanosine 3',5'-cyclic monophosphate, and cyclic adenosine monophosphate with reduced spreading on